Z Squared ZSQR
NASDAQ ZSQR
$2.58 +0.28 (+11.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Z Squared (ZSQR) EBITDA Margin (2025 - 2026)

Updated

Z Squared's EBITDA Margin was -809.21% in Q2 2026, up 2372.04 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBITDA Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBITDA Margin was -705.00% through Jun 30, 2026, up 11797.09 percentage points year-over-year; for FY2025, it was -870.28%.

  • EBITDA Margin shows a four-year change of +17261.08 percentage points (FY2021 to FY2025).
  • In earlier years, EBITDA Margin was -18131.36% in FY2021.
  • Quarterly EBITDA Margin has moved between -5982.89% (Q1 2025) and -196.39% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBITDA Margin in the three quarters before Q2 2026 was -3181.25% (Q1 2026), -196.39% (Q4 2025) and -670.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Z Squared 121.90 Mn 95.14 Mn -1.77 Mn -809.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -809.21%
Mar 31, 2026 -3,181.25%
Dec 31, 2025 -196.39%
Sep 30, 2025 -645.69%
Mar 31, 2025 -5,824.03%
API Access

Z Squared EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY